From the Division of Ortho Alliance NJ, Orthopedic Institute Brielle Orthopaedics, Manasquan, NJ (Siddiqi), the Department of Orthopedic Surgery, Hackensack Meridian School of Medicine, Nutley, NJ (Siddiqi), the Department of Orthopedic Surgery, Jersey Shore University Medical Center, Hackensack Meridian Health, Neptune, NJ (Siddiqi), the Department of Orthopedics, OrthoVirginia, Reston, VA (Alamanda), Plano Orthopedic and Sports Medicine Center, Plano, TX (Barrington), the Department of Orthopedic Surgery, Brigham and Woman's Hospital, Boston, MA (Chen), the American Joint Replacement Registry, American Academy of Orthopedic Surgeons, Chicago, IL (De, Mullen, and Porter), the Department of Orthopedic Surgery, Stanford, Redwood City, CA (Huddlesto), the Department of Orthopedic Surgery, Dell Medical School, The University of Texas at Austin, Austin, TX (Bozic), the Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN (Lewallen), the Department of Orthopedic Surgery, Cleveland Clinic Foundation, Cleveland, OH (Piuzzi), and the Department of Orthopedics Atrium Musculoskeletal Institute (Springer), OrthoCarolina Hip and Knee Center, Charlotte, NC.
Correspondence to Dr. Siddiqi: [email protected]
Siddiqi or an immediate family member serves as an unpaid consultant to AZ Solutions and LLC, and paid consultant to Intellijoint Surgical and ROMTech and has stock options in ROMTech, none of which are relevant to this article. Chen or an immediate family member serves as a board member of American Academy of Orthopaedic Surgeons, AJRR, AAHKS, Annals of Joint, CORR, European Knee Association, Healthcare Transformation ICJR, JOA, JBJI, JBJS, JOR, KSSTA, and MSIS and receives royalties and paid consultant to AMA, ConvaTec, Ethicon, GLG, Graftworx, Guidepoint, Heraeus, Hyalex, Irrimax, Joint Purification System, Pfizer, PhagoMed, Recro, SLACK incorporated, Sonoran, Stryker, and UpToDate, none of which are relevant to this article. Huddleston or an immediate family member serves as a board member of American Academy of Orthopaedic Surgeons and AAHKS; receives research support from Apple; serves as a paid consultant to Biomet, CMS/Yale CORE, Corin, Depuy, Exactech, and Zimmer Bioment; receives royalties from Depuy and Exactech; board member for JOA and Knee Society; and holds stock options in PorOsteon, none of which are relevant to this article. Barrington or an immediate family member serves as a board member for AJRR; serves as a paid consultant to Biomet, Flexion Therapeutics, Kyocera, and Smith and Nephew; receives royalties from DJO; holds stock options in Iconacy; and receives royalties from Zimmer, none of which are relevant to this article. Springer or an immediate family member serves as a board member of Knee Society, AJRR, AAHKS, Arthroplasty Today, and Journal of Arthroplasty; serves as a paid consultant to CeramTec, ConvaTec, Joint purifications systems, and osteoremedies; and receives royalties from Stryker, not relevant to this article. Bozic or an immediate family member serves as a board member of American Academy of Orthopaedic Surgeons; holds stock options in Carrum Health; serves as a paid consultant to CMS and Purchaser business Group on Health, and unpaid consultant to HBS; receives financial or material support from OM1; and serves as a governing board of SLACK, none of which are relevant to this article. Lewallen or an immediate family member has stock option in Acuitive Technologies and Ketai Medical Devices; receives research support from Corin; serves as a board member of Orthopedic Research and Education Foundation; and serves as paid consultant for Zimmer Biomet, none of which are relevant to this article. Piuzzi or an immediate family member serves as a board member of ISCT; governing board member of Journal of Knee Surgery, Journal of Hip Surgery, and Orthopaedic Research Society; and receives research support from RegenLab and Zimmer-Biomet, not relevant to this article. None of the following authors or any immediate family member has received anything of value from or has stock or stock options held in a commercial company or institution related directly or indirectly to the subject of this article: De, Porter, Mullen, and Alamanda.
